Literature DB >> 12694313

Do circulating cytokines really matter in sepsis?

Ciro Tetta1, Rinaldo Bellomo, Vincent D'Intini, Concetta De Nitti, Paola Inguaggiato, Alessandra Brendolan, Claudio Ronco.   

Abstract

Sepsis remains the major cause of mortality worldwide, claiming millions of lives each year. The past decade has seen major advances in the understanding of the biological mechanisms involved in this complex process. Unfortunately, no definitive therapy yet exists that can successfully treat sepsis and its complications. In this review, we will address the significance of circulating cytokines in the pathophysiology of sepsis and its relevance to new approaches in extracorporeal therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694313     DOI: 10.1046/j.1523-1755.63.s84.40.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  4 in total

1.  Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure.

Authors:  M K Holly; J W Dear; X Hu; A N Schechter; M T Gladwin; S M Hewitt; P S T Yuen; R A Star
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

Review 2.  Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury.

Authors:  John R Prowle; Antoine Schneider; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-03-18       Impact factor: 9.097

3.  Measurement of functional and morphodynamic neutrophil phenotypes in systemic inflammation and sepsis.

Authors:  Rens Zonneveld; G Molema; Frans B Plötz
Journal:  Crit Care       Date:  2016-08-24       Impact factor: 9.097

4.  Angiotensin AT2 Receptor is Anti-inflammatory and Reno-Protective in Lipopolysaccharide Mice Model: Role of IL-10.

Authors:  Naureen Fatima; Sanket Patel; Tahir Hussain
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.